首页> 美国卫生研究院文献>Aging (Albany NY) >Colon cancer combined with obesity indicates improved survival- research on relevant mechanism
【2h】

Colon cancer combined with obesity indicates improved survival- research on relevant mechanism

机译:结肠癌结合肥胖症表明了对相关机制的生存研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Obesity contributes to the incidence of various tumors, including colon cancer. However, the impact of obesity on patients’ survival and related mechanisms remains unclear. Multi-omics data of 227 cases of colon cancer patients combined with clinical characteristics data were acquired from The Cancer Genome Atlas (TCGA) database. We confirmed obesity as an independent prognostic factor for improved overall survival of colon cancer patients. We demonstrated that hypoxia pathways were repressed in obese patients by regulating miR-210. Immune checkpoints PD-1 and LAG3 were also downregulated in obese patients, which indicated enhanced immune surveillance. The frequency of PIK3CA and KRAS mutations was decreased in obese patients. The sites and types of TP53 mutation were alternated in obesity patients. In conclusion, our research demonstrated the potential mechanisms of prolonged survival in colon cancer patients combined with obesity, which may provide potential value for improving the prognosis of colon cancer.
机译:肥胖有助于各种肿瘤的发病率,包括结肠癌。然而,肥胖对患者的生存和相关机制的影响尚不清楚。从癌症基因组Atlas(TCGA)数据库中获得227例结合临床特征数据227例结肠癌患者的多OMICS数据。我们确认肥胖症作为一种改善结肠癌患者整体存活的独立预后因素。我们证明,通过调节miR-210,在肥胖患者中抑制了缺氧途径。免疫检查点PD-1和LAG3也在肥胖患者中下调,这表明免疫监测增强。肥胖患者的PIK3CA和KRAS突变的频率降低。 TP53突变的遗址和类型在肥胖症患者中交替。总之,我们的研究表明,结肠癌患者的长期生存潜在机制伴有肥胖症,这可能为改善结肠癌预后提供潜在的价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号